Ribavirin Completed Phase 4 Trials for Hepatitis C Viral Infection Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT02156570DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)
NCT02601976Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population
NCT01756079A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105)
NCT02214420SMV + SOF With/Without RBV for IFN-II Patients With CHC
NCT02992457Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection
NCT00993122Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients
NCT01045278Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy
NCT00207363Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC
NCT00203606Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C
NCT00207402Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin
NCT00192569Australian Trial in Acute Hepatitis C
NCT00241618Timing and Duration of Acute Hepatitis C Treatment
NCT00266318Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy
NCT00277862Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4
NCT00383864Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.
NCT00502099Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4
NCT00560690The Effect of Adding Metformin to the Treatment of Hepatitis C
NCT00056862Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
NCT01937728Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1)